Moderna Biotech Company

Dear customer, upon your request Moderna Biotech Company were found the following resources. Our team makes effort to make you happy with the search on our site ninan.org

Moderna Therapeutics is pioneering a new class of drugs, messenger RNA Therapeutics, with the vast potential to treat many diseases across a range of drug modalities and therapeutic areas.…

Moderna, Inc. is a Cambridge, Massachusetts-based biotechnology company that is focused on drug discovery and drug development based on messenger RNA (mRNA). The company creates synthetic mRNA that can be injected into patients to help them create their own therapies.Headquarters: Cambridge, Massachusetts, U.S.…

Moderna's pipeline highlights where we're advancing mRNA vaccines and therapies for MMA, CMV, Zika virus, rare diseases, cancers, cardiovascular disease and more.…

Dec 27, 2018 · Moderna set a historic record of raising $604 million this year. It also became the biotech company with the highest IPO (Initial Public Offer), valuing the company at $7.5 billion. That’s more than 56 other biotech companies combined and it doesn’t even have a marketable product yet.…

Dec 07, 2018 · Moderna Inc. raised over $600 million Thursday in biotech’s largest initial public offering to date. Moderna sold about 26.3 million shares priced at $23 a share late Thursday, at the midpoint ...…

Feb 25, 2020 · US biotech firm Moderna has shipped an experimental coronavirus vaccine to US government researchers just six weeks after it started working on the immunization.…

Jan 09, 2020 · The biotech company Moderna is inching closer to commercialization, with positive new interim data on the Phase 1 study of its Cytomegalovirus vaccine and news that the company ……

The Investor Relations website contains information about Moderna, Inc.'s business for stockholders, potential investors, and financial analysts.…

Jan 22, 2020 · Moderna on Tuesday said it is working with U.S. government health agencies to develop a vaccine for the current strain of coronavirus that has killed nine and infected hundreds more in China.Author: Terri Cullen…

In total, the company is raising $620 million in the offering, making it the biggest initial public offering in biotech history. Moderna is developing medical treatments based on messenger RNA ...…